Company · founded 1991
BioScience Laboratories (United States)
Bozeman, United States · biosciencelabs.com
- Citations, last 5 years
- 9
- Works, last 5 years
- 4
- h-index
- 37
- Scientists listed
- 0
- Grants since 2016
- 188
Grants received
2025–2026 · contract · N01
Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2025–2026 · contract · N01
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2025–2026 · contract · N01
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2024–2025 · contract · N01
Use of Artificial Intelligence/Machine Learning (AI/ML) to Enhance the STEP Pediatric Excipient Database
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2024–2025 · contract · N01
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Trained Human Sensory Panels
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2024–2025 · contract · N01
Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2024–2027 · contract · N01
CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN
Christina Mayer · BioScience Laboratories (United States) · funded by National Institutes of Health
2023–2025 · contract · N01
cGMP Manufacturing of Monoclonal Antibodies (mAbs) Against HIV
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2023–2024 · contract · N01
Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2023–2030 · contract · N01
TASK A: NIAID Preclinical Services for AMR Diagnostics Development - Product Development Processes and Documentation
Christina Mayer · BioScience Laboratories (United States) · funded by National Institutes of Health
2023–2025 · contract · N01
Task V31: Process Development for Panfungal Vaccine
Tim Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2023 · contract · N01
Task X6: Development of Candida Vaccines
James Richardson · BioScience Laboratories (United States) · funded by National Institutes of Health
2023–2024 · contract · N01
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2023–2025 · contract · N01
Task V31: Process Development for a Panfungal Vaccine
Tim Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2022 · contract · N01
CONTRACT KICKOFF MEETING AND PROJECT MANAGEMENT PLAN
Cary Retterer · BioScience Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
Ethnographic Expertise for Enhancing Study Drug Adherence in HIV Prevention Trials
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2022–2024 · contract · N01
NIAID Preclinical Development Support: Essential Core Activities
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
Expertise in Development of Pediatric Drug Formulations
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
Statistical and Pharmacometric Modeling Support for HIV Non-Vaccine Biomedical Prevention Product Development
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
Characterization of Drug Substances in a Dual Indication Vaginal Ring for Prevention of HIV and Pregnancy
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2022–2026 · contract · N01
Task V30: GMP Manufacturing of WNV Vaccine
Tim Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2022–2024 · cooperative agreement · Cooperative Agreement
SBIR Phase II: Microbial Discovery and Biosynthesis of Targeted Protease Inhibitors (COVID-19)
Matthew Traylor · BioScience Laboratories (United States) · funded by National Science Foundation
2022–2023 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC)
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2022–2023 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Material Receipt, Storage, Shipping and Inventory
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2022–2030 · contract · N01
CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN
Christina Mayer · BioScience Laboratories (United States) · funded by National Institutes of Health
2021–2022 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC)
Maria Grazia Ferrari · BioScience Laboratories (United States) · funded by National Institutes of Health
2021–2022 · contract · N01
Expertise in Development of Pediatric Drug Formulations
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2021–2027 · contract · N01
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2021–2022 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Material Receipt, Storage, Shipping and Inventory
Peter Silvera · BioScience Laboratories (United States) · funded by National Institutes of Health
2021–2023 · contract · N01
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2021–2024 · contract · N01
Stability Testing of HIV Antibodies and Reagents Used in Downstream Process Purification
Fouts Timothy · BioScience Laboratories (United States) · funded by National Institutes of Health
2021–2023 · contract · N01
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2021–2022 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
Maria Grazia Ferrari · BioScience Laboratories (United States) · funded by National Institutes of Health
2021–2025 · contract · N01
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
Support for Enhancing Study Drug Adherence in HIV Prevention Trials
Maria Grazia Ferrari · BioScience Laboratories (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
Ranajit Pal · BioScience Laboratories (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
NIAID Preclinical Development Support: Essential Core Activities
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
NIAID Preclinical Development Support: Essential Core Activities
Timothy Fouts · BioScience Laboratories (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
Ethnographic Expertise for Enhancing Study Drug Adherence in HIV Prevention Trials
Maria Grazia Ferrari · BioScience Laboratories (United States) · funded by National Institutes of Health
